Annual EBIT
-$22.01 M
+$14.32 M+39.41%
December 31, 2024
Summary
- As of February 26, 2025, ITRM annual earnings before interest & taxes is -$22.01 million, with the most recent change of +$14.32 million (+39.41%) on December 31, 2024.
- During the last 3 years, ITRM annual EBIT has risen by +$63.29 million (+74.20%).
- ITRM annual EBIT is now -64.87% below its all-time high of -$13.35 million, reached on December 31, 2016.
Performance
ITRM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$5.68 M
-$315.00 K-5.87%
December 1, 2024
Summary
- As of February 26, 2025, ITRM quarterly earnings before interest & taxes is -$5.68 million, with the most recent change of -$315.00 thousand (-5.87%) on December 1, 2024.
- Over the past year, ITRM quarterly EBIT has dropped by -$315.00 thousand (-5.87%).
- ITRM quarterly EBIT is now -163.85% below its all-time high of $8.90 million, reached on June 30, 2021.
Performance
ITRM Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$22.01 M
+$6.13 M+21.79%
December 1, 2024
Summary
- As of February 26, 2025, ITRM TTM earnings before interest & taxes is -$22.01 million, with the most recent change of +$6.13 million (+21.79%) on December 1, 2024.
- Over the past year, ITRM TTM EBIT has increased by +$6.13 million (+21.79%).
- ITRM TTM EBIT is now -356.88% below its all-time high of $8.57 million, reached on March 31, 2022.
Performance
ITRM TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ITRM EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.4% | -5.9% | +21.8% |
| 3 y3 years | +74.2% | -5.9% | +21.8% |
| 5 y5 years | +78.4% | -5.9% | +21.8% |
ITRM EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.2% | -179.4% | +80.4% | -356.9% | +74.2% |
| 5 y | 5-year | at high | +78.4% | -163.8% | +94.1% | -356.9% | +81.5% |
| alltime | all time | -64.9% | +78.4% | -163.8% | +94.1% | -356.9% | +81.5% |
Iterum Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$22.01 M(-39.4%) | - | - |
| Dec 2024 | - | -$5.68 M(+5.9%) | -$22.01 M(-21.8%) |
| Sep 2024 | - | -$5.37 M(+22.1%) | -$28.14 M(+7.5%) |
| Jun 2024 | - | -$4.39 M(-33.1%) | -$26.19 M(-21.9%) |
| Mar 2024 | - | -$6.57 M(-44.4%) | -$33.53 M(-7.7%) |
| Dec 2023 | -$36.33 M(-13.0%) | -$11.81 M(+245.9%) | -$36.33 M(+22.8%) |
| Sep 2023 | - | -$3.42 M(-70.9%) | -$29.58 M(-46.4%) |
| Jun 2023 | - | -$11.73 M(+25.2%) | -$55.21 M(+12.4%) |
| Mar 2023 | - | -$9.37 M(+84.8%) | -$49.10 M(+17.6%) |
| Dec 2022 | -$41.77 M(-51.0%) | -$5.07 M(-82.5%) | -$41.77 M(+4.6%) |
| Sep 2022 | - | -$29.04 M(+416.2%) | -$39.94 M(+570.5%) |
| Jun 2022 | - | -$5.63 M(+176.6%) | -$5.96 M(-169.5%) |
| Mar 2022 | - | -$2.03 M(-37.2%) | $8.57 M(-110.0%) |
| Dec 2021 | -$85.31 M(+135.9%) | -$3.24 M(-165.5%) | -$85.31 M(-4.1%) |
| Sep 2021 | - | $4.94 M(-44.5%) | -$88.99 M(-12.3%) |
| Jun 2021 | - | $8.90 M(-109.3%) | -$101.52 M(-14.5%) |
| Mar 2021 | - | -$95.91 M(+1286.2%) | -$118.69 M(+228.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$36.17 M(-64.5%) | -$6.92 M(-8.9%) | -$36.17 M(-31.0%) |
| Sep 2020 | - | -$7.60 M(-8.1%) | -$52.43 M(-30.8%) |
| Jun 2020 | - | -$8.27 M(-38.2%) | -$75.79 M(-20.1%) |
| Mar 2020 | - | -$13.38 M(-42.3%) | -$94.87 M(-6.8%) |
| Dec 2019 | -$101.83 M(+33.7%) | -$23.19 M(-25.1%) | -$101.83 M(-0.5%) |
| Sep 2019 | - | -$30.95 M(+13.2%) | -$102.36 M(+6.6%) |
| Jun 2019 | - | -$27.35 M(+34.4%) | -$96.07 M(+13.9%) |
| Mar 2019 | - | -$20.34 M(-14.3%) | -$84.33 M(+10.7%) |
| Dec 2018 | -$76.16 M(+158.6%) | -$23.73 M(-3.8%) | -$76.19 M(+23.5%) |
| Sep 2018 | - | -$24.66 M(+58.0%) | -$61.67 M(+36.1%) |
| Jun 2018 | - | -$15.60 M(+27.9%) | -$45.31 M(+25.4%) |
| Mar 2018 | - | -$12.20 M(+32.6%) | -$36.12 M(+22.3%) |
| Dec 2017 | -$29.45 M(+120.6%) | -$9.20 M(+10.9%) | -$29.52 M(+45.3%) |
| Sep 2017 | - | -$8.30 M(+29.4%) | -$20.32 M(+69.0%) |
| Jun 2017 | - | -$6.41 M(+14.3%) | -$12.02 M(+114.3%) |
| Mar 2017 | - | -$5.61 M | -$5.61 M |
| Dec 2016 | -$13.35 M | - | - |
FAQ
- What is Iterum Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Iterum Therapeutics?
- What is Iterum Therapeutics annual EBIT year-on-year change?
- What is Iterum Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly EBIT year-on-year change?
- What is Iterum Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Iterum Therapeutics?
- What is Iterum Therapeutics TTM EBIT year-on-year change?
What is Iterum Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ITRM is -$22.01 M
What is the all time high annual EBIT for Iterum Therapeutics?
Iterum Therapeutics all-time high annual earnings before interest & taxes is -$13.35 M
What is Iterum Therapeutics annual EBIT year-on-year change?
Over the past year, ITRM annual earnings before interest & taxes has changed by +$14.32 M (+39.41%)
What is Iterum Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ITRM is -$5.68 M
What is the all time high quarterly EBIT for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly earnings before interest & taxes is $8.90 M
What is Iterum Therapeutics quarterly EBIT year-on-year change?
Over the past year, ITRM quarterly earnings before interest & taxes has changed by -$315.00 K (-5.87%)
What is Iterum Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ITRM is -$22.01 M
What is the all time high TTM EBIT for Iterum Therapeutics?
Iterum Therapeutics all-time high TTM earnings before interest & taxes is $8.57 M
What is Iterum Therapeutics TTM EBIT year-on-year change?
Over the past year, ITRM TTM earnings before interest & taxes has changed by +$6.13 M (+21.79%)